[An external antirheumatic drug under examination--possibilities and limits of a clinical trial].
D000287:Administration, Topical; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D005356:Fibromyalgia / Q000188:drug therapy*; D005439:Flufenamic Acid / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012459:Salicylates / Q000627:therapeutic use*; D013128:Spinal Osteophytosis / Q000188:drug therapy; D013729:Terpenes / Q000627:therapeutic use*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004338:Drug Combinations; D012459:Salicylates; D013729:Terpenes; C027860:diethylamine salicylate, flufenamic acid, myrtecaine drug combination; D005439:Flufenamic Acid
Ein externes Antirheumatikum in der Prüfung--Möglichkeiten und Grenzen des Feldversuchs.